Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify two clinico-biological subtypes
Blood Adv
.
2024 Oct 29:bloodadvances.2024013327.
doi: 10.1182/bloodadvances.2024013327.
Online ahead of print.
Authors
Stella Charalampopoulou
1
,
Elise Chapiro
2
,
Ferran Nadeu
3
,
Thorsten Zenz
4
,
Silvia Beà
1
,
Marta Aymerich
5
,
Ares Martinez-Farran
1
,
Maria Rozman
6
,
Damien Roos-Weil
7
,
Olivier A Bernard
8
,
Santos A Susin
9
,
Helen Parker
10
,
Renata Walewska
11
,
Christopher C Oakes
12
,
Jonathan C C Strefford
10
,
Elías Campo
3
,
Estella Matutes
13
,
Martí Duran-Ferrer
3
,
Florence Nguyen-Khac
14
,
Jose Ignacio Martin-Subero
1
Affiliations
1
IDIBAPS, Barcelona, Spain.
2
AP-HP, PARIS, France.
3
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
4
University of Zurich, Zürich, Switzerland.
5
Hospital Clínic of Barcelona, Barcelona, Spain.
6
Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
7
Pitié-Salpêtrière, paris, France.
8
INSERM, Villejuif cedex, France.
9
Centre de Recherche des Cordeliers, Paris, France.
10
University of Southampton, Southampton, United Kingdom.
11
University Hospitals Dorset, Bournemouth, United Kingdom.
12
The Ohio State University, Columbus, Ohio, United States.
13
Hospital Clinic. University of Barcelona, Barcelona, Spain.
14
Hopital Pitie-Salpetriere, Sorbonne Universite, Paris, France.
PMID:
39471431
DOI:
10.1182/bloodadvances.2024013327
No abstract available